Edition:
United Kingdom

Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

20.00USD
20 Feb 2019
Change (% chg)

-- (--)
Prev Close
$20.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
18,827
52-wk High
$25.57
52-wk Low
$7.74

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Oct 5.59 -0.219
Jul 3.72 -0.466
FY 2018 Apr '18 4.84 -0.061
Jan '18 2.33 -0.485
Oct 1.13 -0.498
Jul 0.10 -0.507
FY 2017 Apr '17 0.11 -0.440
Jan '17 0.25 -0.998
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jan-19 5 3.94 5.03 3.00 --
Quarter Ending Apr-19 5 4.06 5.03 3.00 --
Year Ending Apr-19 5 16.40 17.70 15.30 14.40
Year Ending Apr-20 4 27.43 43.80 10.00 28.80
Earnings (per share)
Quarter Ending Jan-19 5 -0.48 -0.41 -0.62 --
Quarter Ending Apr-19 5 -0.49 -0.33 -0.79 --
Year Ending Apr-19 5 -1.64 -1.07 -2.11 -1.40
Year Ending Apr-20 4 -2.11 -0.26 -4.21 -0.27
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.48 33.70
P/E High - Last 5 Yrs. -- 44.98 49.87
P/E Low - Last 5 Yrs. -- 23.63 24.25
Beta -- 0.90 0.90
Price to Sales (TTM) 151.44 4.12 6.29
Price to Book (MRQ) 2.63 5.10 5.26
Price to Tangible Book (MRQ) 2.63 5.85 6.77
Price to Cash Flow (TTM) -- 24.01 24.98
% Owned Institutions 80.82 0.90 1.69

Dividends

  Company industry sector
Dividend Yield -- 1.49 1.40
Dividend Yield - 5 Year Avg -- 1.51 1.42
Dividend 5 Year Growth Rate -- 4.15 4.85
Payout Ratio(TTM) -- 43.91 41.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 1,271.43 4.31 12.75
Sales (TTM) vs TTM 1 Yr. Ago 1,503.45 4.07 5.84
Sales - 5 Yr. Growth Rate -- 10.91 11.23
EPS (MRQ) vs Qtr. 1 Yr. Ago 87.02 44.94 47.15
EPS (TTM) vs TTM 1 Yr. Ago 75.80 -- --
EPS - 5 Yr. Growth Rate -- 10.31 10.85
Capital Spending - 5 Yr. Growth Rate -- 15.88 15.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.15 2.25
Current Ratio (MRQ) 7.87 2.97 3.08
LT Debt to Equity (MRQ) 0.80 8.85 11.38
Total Debt to Equity (MRQ) 1.55 12.89 16.12
Interest Coverage (TTM) -29.72 33.79 29.47

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 53.68 53.81
Gross Margin - 5 Yr. Avg. -- 51.67 52.18
EBITD Margin (TTM) -4,520.00 -- --
EBITD - 5 Yr. Avg -- 17.96 12.87
Operating Margin (TTM) -4,529.25 14.31 6.20
Operating Margin - 5 Yr. Avg. -- 14.24 8.31
Pre-Tax Margin (TTM) -4,120.21 14.85 7.16
Pre-Tax Margin - 5 Yr. Avg. -- 14.68 8.61
Net Profit Margin (TTM) -4,120.21 11.08 3.30
Net Profit Margin - 5 Yr. Avg. -- 11.02 4.89
Effective Tax Rate (TTM) -- 23.02 22.91
Effective Tax Rate - 5 Yr. Avg. -- 23.16 23.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 957,633,954 842,398,385
Net Income/Employee (TTM) -- 113,563,169 99,842,801
Receivable Turnover (TTM) -- 5.71 5.71
Inventory Turnover (TTM) -- 2.61 3.47
Asset Turnover (TTM) 0.01 0.97 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -55.70 11.52 11.06
Return on Assets - 5 Yr. Avg. -- 12.92 12.20
Return on Investment (TTM) -60.80 14.95 14.45
Return on Investment - 5 Yr. Avg. -- 16.84 15.87
Return on Equity (TTM) -61.05 16.27 15.96
Return on Equity - 5 Yr. Avg. -- 17.77 17.00
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -- -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Kalvista Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -12.01 -15.05 9 22
13 Week 1.40 -3.54 60 39
26 Week -3.33 -10.68 47 33
52 Week -4.10 -18.72 43 9
YTD 2.55 -9.94 46 26
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 82.17%
# of Holders: 75
Total Shares Held: 14,153,572
3 Mo. Net Change: 669,275
# New Positions: 27
# Closed Positions: 10
# Increased Positions: 47
# Reduced Positions: 23
# Net Buyers: 24
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.